BOM:530233 (India)
Â
Shs Dematerialised
₹
207.85
(-2.94%)
May 29
Business Description
Auro Laboratories Ltd
ISIN : INE292C01011
Share Class Description:
BOM:530233: Shs DematerialisedCompare
Compare
Traded in other countries / regions
530233.India IPO Date
2000-11-13Description
Auro Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and selling of pharmaceutical products like Metformin Hydrochloride and Glibenclamide. The pharmaceutical products range offered by the company are anti-diabetic, muscle relaxant, diuretic, iron deficiency anti-fungal, anti-ulcer, iodine supplement, anti-malaria, antacids, anti-inflammatory, specialty chemicals, and others. The company sells its products in India and also exports it to international countries.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.33 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.63 | |||||
| Debt-to-EBITDA | 2.46 | |||||
| Interest Coverage | 18.57 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.04 | |||||
| Beneish M-Score | -3.3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.4 | |||||
| 3-Year EBITDA Growth Rate | 0.5 | |||||
| 3-Year EPS without NRI Growth Rate | 2.8 | |||||
| 3-Year Book Growth Rate | 13.7 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 25.42 | |||||
| 9-Day RSI | 36.16 | |||||
| 14-Day RSI | 43.07 | |||||
| 6-1 Month Momentum % | 60.9 | |||||
| 12-1 Month Momentum % | 152.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.29 | |||||
| Quick Ratio | 0.94 | |||||
| Cash Ratio | 0.37 | |||||
| Days Inventory | 183.57 | |||||
| Days Sales Outstanding | 98.29 | |||||
| Days Payable | 170.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -10.14 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 52.62 | |||||
| Operating Margin % | 20.01 | |||||
| Net Margin % | 16.3 | |||||
| FCF Margin % | -38.74 | |||||
| ROE % | 18.78 | |||||
| ROA % | 10.47 | |||||
| ROIC % | 13.19 | |||||
| ROC (Joel Greenblatt) % | 21.57 | |||||
| ROCE % | 20.01 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.28 | |||||
| PE Ratio without NRI | 18.28 | |||||
| Shiller PE Ratio | 29.28 | |||||
| Price-to-Owner-Earnings | 19.85 | |||||
| PEG Ratio | 11.43 | |||||
| PS Ratio | 2.98 | |||||
| PB Ratio | 3.09 | |||||
| Price-to-Tangible-Book | 3.09 | |||||
| Price-to-Operating-Cash-Flow | 6.89 | |||||
| EV-to-EBIT | 14.95 | |||||
| EV-to-EBITDA | 13.8 | |||||
| EV-to-Revenue | 3.38 | |||||
| EV-to-FCF | -8.73 | |||||
| Price-to-Projected-FCF | 3.59 | |||||
| Price-to-DCF (Earnings Based) | 0.77 | |||||
| Price-to-Median-PS-Value | 3.49 | |||||
| Price-to-Graham-Number | 1.42 | |||||
| Earnings Yield (Greenblatt) % | 6.69 | |||||
| FCF Yield % | -12.99 | |||||
| Forward Rate of Return (Yacktman) % | 1.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Auro Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 434.526 | ||
| EPS (TTM) (₹) | 11.37 | ||
| Beta | 0.4 | ||
| Volatility % | 79.8 | ||
| 14-Day RSI | 43.07 | ||
| 14-Day ATR (₹) | 14.674423 | ||
| 20-Day SMA (₹) | 241.79 | ||
| 12-1 Month Momentum % | 152.87 | ||
| 52-Week Range (₹) | 75.12 - 307.2 | ||
| Shares Outstanding (Mil) | 6.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Auro Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Auro Laboratories Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Auro Laboratories Ltd Frequently Asked Questions
What is Auro Laboratories Ltd(BOM:530233)'s stock price today?
The current price of BOM:530233 is ₹207.85. The 52 week high of BOM:530233 is ₹307.20 and 52 week low is ₹75.12.
When is next earnings date of Auro Laboratories Ltd(BOM:530233)?
The next earnings date of Auro Laboratories Ltd(BOM:530233) is .
Does Auro Laboratories Ltd(BOM:530233) pay dividends? If so, how much?
Auro Laboratories Ltd(BOM:530233) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers